Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marzena Wylezinska-Arridge

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Aerospace Medicine and Human Performance|October 21, 2024
Brain Magnetic Resonance Imaging Responses to Nonhypoxic Hypobaric DecompressionDesmond Connolly, Indran Davagnanam, Marzena Wylezinska-Arridge, et al.
EJNMMI Research|January 5, 2012
Imaging technologies for preclinical models of bone and joint disordersJordi L Tremoleda, Magdy Khalil, Luke L Gompels, et al.
Journal of Materials Chemistry. B|April 9, 2020
RGD-targeted MnO nanoparticles as T<sub>1</sub> contrast agents for cancer imaging - the effect of PEG length in vivoJuan Gallo, Israt S Alam, Ioannis Lavdas, et al.
Angewandte Chemie (International Ed. in English)|July 22, 2014
CXCR4-targeted and MMP-responsive iron oxide nanoparticles for enhanced magnetic resonance imagingJuan Gallo, Nazila Kamaly, Ioannis Lavdas, et al.
Radiology|March 20, 2008
Liver fat content and T2*: simultaneous measurement by using breath-hold multiecho MR imaging at 3.0 T--feasibilityDeclan P O'Regan, Martina F Callaghan, Marzena Wylezinska-Arridge, et al.
Psychopharmacology|December 30, 2011
Age-dependent effects of chronic fluoxetine treatment on the serotonergic system one week following treatmentValentine Bouet, Anne Klomp, Thomas Freret, et al.
Chemical Communications (Cambridge, England)|December 5, 2012
Gd3+ cFLFLFK conjugate for MRI: a targeted contrast agent for FPR1 in inflammationGraeme J Stasiuk, Helen Smith, Marzena Wylezinska-Arridge, et al.
Biomedical Optics Express|July 14, 2011
In vivo fluorescence lifetime tomography of a FRET probe expressed in mouseJames McGinty, Daniel W Stuckey, Vadim Y Soloviev, et al.
Journal of Vascular Surgery|June 27, 2017
Imaging vulnerable plaques by targeting inflammation in atherosclerosis using fluorescent-labeled dual-ligand microparticles of iron oxide and magnetic resonance imagingJoyce M S Chan, Claudia Monaco, Marzena Wylezinska-Arridge, et al.
Applied Optics|December 24, 2011
Förster resonance energy transfer imaging in vivo with approximated radiative transfer equationVadim Y Soloviev, James McGinty, Daniel W Stuckey, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Aerospace Medicine and Human Performance|October 21, 2024
Brain Magnetic Resonance Imaging Responses to Nonhypoxic Hypobaric DecompressionDesmond Connolly, Indran Davagnanam, Marzena Wylezinska-Arridge, et al.
EJNMMI Research|January 5, 2012
Imaging technologies for preclinical models of bone and joint disordersJordi L Tremoleda, Magdy Khalil, Luke L Gompels, et al.
Journal of Materials Chemistry. B|April 9, 2020
RGD-targeted MnO nanoparticles as T<sub>1</sub> contrast agents for cancer imaging - the effect of PEG length in vivoJuan Gallo, Israt S Alam, Ioannis Lavdas, et al.
Angewandte Chemie (International Ed. in English)|July 22, 2014
CXCR4-targeted and MMP-responsive iron oxide nanoparticles for enhanced magnetic resonance imagingJuan Gallo, Nazila Kamaly, Ioannis Lavdas, et al.
Radiology|March 20, 2008
Liver fat content and T2*: simultaneous measurement by using breath-hold multiecho MR imaging at 3.0 T--feasibilityDeclan P O'Regan, Martina F Callaghan, Marzena Wylezinska-Arridge, et al.
Psychopharmacology|December 30, 2011
Age-dependent effects of chronic fluoxetine treatment on the serotonergic system one week following treatmentValentine Bouet, Anne Klomp, Thomas Freret, et al.
Chemical Communications (Cambridge, England)|December 5, 2012
Gd3+ cFLFLFK conjugate for MRI: a targeted contrast agent for FPR1 in inflammationGraeme J Stasiuk, Helen Smith, Marzena Wylezinska-Arridge, et al.
Biomedical Optics Express|July 14, 2011
In vivo fluorescence lifetime tomography of a FRET probe expressed in mouseJames McGinty, Daniel W Stuckey, Vadim Y Soloviev, et al.
Journal of Vascular Surgery|June 27, 2017
Imaging vulnerable plaques by targeting inflammation in atherosclerosis using fluorescent-labeled dual-ligand microparticles of iron oxide and magnetic resonance imagingJoyce M S Chan, Claudia Monaco, Marzena Wylezinska-Arridge, et al.
Applied Optics|December 24, 2011
Förster resonance energy transfer imaging in vivo with approximated radiative transfer equationVadim Y Soloviev, James McGinty, Daniel W Stuckey, et al.
Pageof 2